MedTrace Logo

Endotracheal Cardiac Output Monitor (ECOM) for Patients Undergoing Liver Transplantation

NCT01299441 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2017-03-24

No results posted yet for this study

Summary

The purpose of this study is to determine whether the endotracheal cardiac output monitor (ECOM) is accurate and predictive in liver failure patients with hyperdynamic circulatory changes.

Conditions

  • Liver Transplantation

Interventions

DEVICE

ECOM ETT

Intubation with ECOM endotracheal tube (ETT)

Sponsors & Collaborators

  • CONMED Corporation

    collaborator INDUSTRY

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Timothy Shine, MD · Mayo Clinic

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2013-12-31
Completion
2016-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01299441 on ClinicalTrials.gov